Recombinant Polypeptide Scaffold for Cartilage Glycosaminoglycan Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current scaffold materials for cartilage tissue restoration and cell culture do not effectively promote extracellular matrix production, particularly glycosaminoglycan production, which is crucial for cartilage health and repair.
Innovation Solution
A recombinant polypeptide with specific amino acid sequences and structural features, including RGD, GFPGER, and GVMGFP sequences, is developed to enhance glycosaminoglycan production by cartilage cells, forming a scaffold that promotes matrix production and tissue repair.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If natural form of type II collagen is used as scaffold material, then biocompatibility is maintained, but extracellular matrix production by cartilage cells is insufficient
Solution Approach 1:
The invention creates a composite polypeptide material that combines type II collagen with specific peptide sequences (RGD, GFPGER, GVMGFP) to achieve both biocompatibility and enhanced extracellular matrix production. The composite structure integrates the natural collagen framework with functional peptide motifs that actively stimulate cartilage cell activity.
Solution Approach 2:
The invention modifies the amino acid sequence parameters of type II collagen by incorporating specific peptide sequences at defined frequencies. The RGD sequence appears at least 0.30 times per 10 kDa, GFPGER at least 0.15 times per 10 kDa, and GVMGFP less than 0.30 times per 10 kDa, creating optimized parametric variations that enhance biological functionality while maintaining structural integrity.
2Strength
If conventional scaffold materials are used, then structural support is provided, but glycosaminoglycan production is not promoted
Solution Approach 1:
The invention introduces specific functional domains (RGD, GFPGER, GVMGFP sequences) at localized positions within the collagen structure. These local quality modifications create specific binding sites and signaling regions that selectively promote glycosaminoglycan production while the overall collagen structure maintains its structural support function.
Solution Approach 2:
The peptide sequences act as intermediaries between the scaffold structure and cartilage cells. The RGD sequence mediates cell adhesion, GFPGER mediates growth factor binding, and GVMGFP mediates matrix production signaling, thereby translating structural support into active glycosaminoglycan production.
Data Source
Figure 1
AI summary
A polypeptide having an amino acid sequence in which the number of RGD sequences contained per molecular weight of 10 kDa is not less than 0.30; the number of GFPGER sequences contained per molecular weight of 10 kDa is not less than 0.15; and the number of GVMGFP sequences contained per molecular weight of 10 kDa is less than 0.30; is provided. A scaffold composition, a composition for repairing a cartilage tissue, a composition for culturing cartilage cells, and a composition for promoting glycosaminoglycan production, which compositions contain the above polypeptide, are also provided.